Concern is growing regarding the abuse of prescription drugs. Kendle already has responded to the growing need to evaluate a new medication's abuse and dependence potential. In fact, we have conducted more abuse liability assessments than any other CRO. Our expert staff, controlled substance facilities and extensive subject database make us the ideal partner to conduct your study and weave the resulting data seamlessly into New Drug Applications.
We have close ties with the FDA when it comes to abuse liability and have developed our own proprietary software system that allows us to measure a wide range of critical endpoints. We can even program tests in advance to match your study’s timing and dosing schedule.